Compartir
Lung Cancer 2021, Part 2, an Issue of Thoracic Surgery Clinics (Volume 31-4) (The Clinics: Surgery, Volume 31-4) (en Inglés)
Shamji Farid M. (Autor)
·
Elsevier
· Tapa Dura
Lung Cancer 2021, Part 2, an Issue of Thoracic Surgery Clinics (Volume 31-4) (The Clinics: Surgery, Volume 31-4) (en Inglés) - Shamji Farid M.
123,24 €
129,72 €
Ahorras: 6,49 €
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Lunes 08 de Julio y el
Viernes 19 de Julio.
Lo recibirás en cualquier lugar de España entre 1 y 5 días hábiles luego del envío.
Reseña del libro "Lung Cancer 2021, Part 2, an Issue of Thoracic Surgery Clinics (Volume 31-4) (The Clinics: Surgery, Volume 31-4) (en Inglés)"
In this issue of Thoracic Surgery Clinics, Guest Editor Farid Shamji brings considerable expertise to the topic of Lung Cancer in this second issue covering this topic. Top experts in the field cover key topics such as biological treatments, improving anesthesia safety in pulmonary resection for lung cancer, history of surgical instruments in thoracic surgery, The Hemithorax - the empty chest syndrome, and more. Provides in-depth, clinical reviews on lung cancer, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Contains 16 relevant, practice-oriented topics including Assessment of Operability and Resectability in Lung Cancer; Complications of chest wall resection in conjunction with pulmonary resection; Sepsis in the postpneumonectomy space: pathogenesis, recognition and management; Neuroendocrine cancers of the lung: natural history, pathological classification, biological behaviour and treatment; and more.